[1] 赵娟,黄旭,刘丽.破骨细胞促进骨重建的研究进展[J].国际口腔医学杂志,2011,38(4)∶423-425 [2] Arron J R, Choi Y. Osteoimmunology: bone versus immune system [J]. Nature, 2000, 408(6812)∶535-536 [3] Y. Li, C. Messina, M. Bendaoud, et al. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease [J]. molecular oral microbiology, 2010, 25(4)∶275-292 [4] 王鑫,史册,郑嵘.白细胞介素-24对破骨细胞功能及分化的影响[J].实用口腔医学杂志,2014,30(4)∶456-459 [5] Wang M, Liang P. Interleukin-24 and its receptors [J]. Immunology, 2005, 114(2)∶166-170 [6] Fisher P B. Is mda-7/IL-24 a "magic bullet" for cancer [J]. Cancer research, 2005, 65(22)∶10128-10138 [7] Sauane M, Gopalkrishnan R V, Lebedeva I, et al. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT‐independent pathways [J]. Journal of cellular physiology, 2003, 196(2)∶334-345 [8] Pellegrini S, Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs) [J]. European Journal of Biochemistry, 1997, 248(3)∶615-633 [9] Hsu YH, Chen WY, Chan CH, et al. Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss [J]. The Journal of experimental medicine, 2011, 208(9)∶1849-1861 [10] Insun Song, Jung Ha Kim, Kabsun Kim, et al. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation [J]. FEBS letter, 2009, 14(583)∶2435-2440 |